• News from ISSCR website tile
  • 6 May, 2020
  • Full story
  • ISSCR 2020 Virtual Square

    ISSCR Takes 2020 Annual Meeting Virtual

  • 14 April, 2020
  • Full story
  • People gathered MFP Mar 2020

    Stem Cell Science is a Global Endeavor

  • 5 March, 2020
  • Full story
  • Pera Martin headshot

    Stem Cell Reports – Advancing Science and the Stem Cell Community

  • 11 February, 2020
  • This month’s message is from Martin Pera, Editor-in-Chief of Stem Cell Reports, the ISSCR’s online, open-access journal. The journal was started in 2013 and publishes high-quality, impactful scientific, and translational discoveries in stem cell science.
    Full story
  • Deepak

    The “I” in the ISSCR

  • 15 January, 2020
  • The International Society for Stem Cell Research (ISSCR) is just that, an international organization. We work across the globe to promote excellence in stem cell science and applications to human health. The society advances international initiatives including: policy and advocacy, professional standards, building working relationships to stay abreast of emerging areas of interest, and of course educational meetings.
    Full story
  • News from ISSCR website tile

    Voting Now Open for 2020 Board of Directors

  • 10 January, 2020
  • Help to shape the future of your society by voting in the 2020 ISSCR Board of Directors election. Together, we offer a collaborative network and powerful resources to help members achieve personal objectives, foster the success of our field and contribute to the betterment of human health. This is your opportunity to make a difference.
    Full story
  • Lawrence Goldstein Policy Fellows Announced

  • 8 October, 2019
  • The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).
    Full story
  • Nominate for ISSCR Awards and Leadership Positions

  • 22 August, 2019
  • The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists and the future of the field, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story
  • Inspiration From the ISSCR 2019 Annual Meeting: Making Meaningful Impacts in 2019 & 2020

  • 9 August, 2019
  • As stem cell researchers, we are in a unique position to make real and meaningful impacts in the world. During my time as ISSCR President my goal, beyond serving ISSCR’s role as the main convener of stem cell science, is to strengthen the society’s voice and influence by expanding on our global policy initiatives and helping foster industry-academic partnerships to accelerate the safe and effective clinical translation of stem cell research.
    Full story
  • ISSCR 2019 Annual Meeting Wrap-up (with photos!)

  • 23 July, 2019
  • Nearly 4,000 scientists, physicians, and stem cell professionals from across the globe gathered at the ISSCR 2019 Annual Meeting in Los Angeles, CA, a vibrant city with world-class stem cell research, to share their discoveries, enhance their careers, and inspire their science.
    Full story
  • What I like most about the ISSCR Annual Meeting

  • 22 July, 2019
  • We asked Naomi Koh Belic, a PhD candidate from the University of Technology Sydney, for her perspective as a trainee attending the ISSCR Annual Meeting for the third year. Naomi shares some highlights and tips from ISSCR2019 in Los Angeles.
    Full story
  • Deepak Srivastava Becomes President of the ISSCR

  • 30 June, 2019
  • The ISSCR is pleased to announce Deepak Srivastava, MD, Gladstone Institutes, as the incoming president of the ISSCR and its board of directors. Srivastava assumed the post immediately following the 17th ISSCR Annual Meeting in Los Angeles, 26-29 June, 2019.
    Full story
  • The ISSCR Announces Establishment of Lawrence Goldstein Science Policy Fellowship

  • 26 June, 2019
  • The ISSCR honored longtime member Lawrence Goldstein for his years of science policy advocacy, and announced a new program in his name that will train ISSCR members to become stem cell policy advocates. The tribute and introduction of the Lawrence Goldstein Science Policy Fellowship program was part of the opening plenary session of the ISSCR annual meeting, 26-29 in Los Angeles, Calif., U.S.
    Full story
  • ISSCR Applauds Landmark Court Ruling in Favor of FDA Regulating Stem Cell Therapies Offered by Florida Clinic

  • 7 June, 2019
  • The ISSCR commends the U.S. District Court ruling that confirms the FDA’s authority to regulate clinics marketing and selling unproven therapies as stem cell products. The clinic, U.S. Stem Cell, has injected cells derived from fat into the eyes of several patients, resulting in at least three being blinded.
    Full story
  • ISSCR Opposes Health and Human Services Policy Restricting Fetal Tissue Research

  • 5 June, 2019
  • The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding for fetal tissue research in the National Institutes of Health (NIH) intramural research program. This research has long been viewed as good public policy to improve human health and has proceeded with public support.
    Full story
  • How to Prepare for ISSCR 2019: Tips from Your Graduate Student Colleagues

  • 24 May, 2019
  • The annual meeting can be overwhelming, with new scientific discoveries to learn about and colleagues to meet. We asked two trainee members, Kimberley Babos and Louise Menendez, for their thoughts about how they plan ahead to ensure they make the most out of their time at the meeting.
    Full story
  • ISSCR Applauds Health Canada’s New Policy Statement re Autologous Cell Therapy Products

  • 20 May, 2019
  • The ISSCR welcomes the new policy guidance from Health Canada that clarifies the regulation of autologous cell products in Canada. The new policy guidance aligns Canada’s regulations with the U.S. Food and Drug Administration’s 2017 Regenerative Medicine Framework and the Australian Therapeutic Goods Administration’s 2018 Autologous human cell and tissue product regulations.
    Full story
    View All ISSCR News